A Study to Evaluate the Long-term Efficacy and Safety of AK102 in Patients With Hyperlipidemia
NCT05255458
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
122
Enrollment
INDUSTRY
Sponsor class
Conditions
Hyperlipidemia
Interventions
BIOLOGICAL:
AK102
DRUG:
Placebo
Sponsor
Akeso